AUB ScholarWorks

Review of meningococcal vaccines with updates on immunization in adults

Show simple item record

dc.contributor.author Zahlanie Y.C.
dc.contributor.author Hammadi M.M.
dc.contributor.author Ghanem S.T.
dc.contributor.author Dbaibo G.S.
dc.contributor.editor
dc.date 2014
dc.date.accessioned 2017-10-05T16:01:24Z
dc.date.available 2017-10-05T16:01:24Z
dc.date.issued 2014
dc.identifier 10.4161/hv.27739
dc.identifier.isbn
dc.identifier.issn 21645515
dc.identifier.uri http://hdl.handle.net/10938/19490
dc.description.abstract Meningococcal disease is a serious and global life-threatening disease. Six serogroups (A, B, C, W-135, X, and Y) account for the majority of meningococcal disease worldwide. Meningococcal polysaccharide vaccines were introduced several decades ago and have led to the decline in the burden of disease. However, polysaccharide vaccines have several limitations, including poor immunogenicity in infants and toddlers, short-lived protection, lack of immunologic memory, negligible impact on nasopharyngeal carriage, and presence of hyporesponsiveness after repeated doses. The chemical conjugation of plain polysaccharide vaccines has the potential to overcome these drawbacks. Meningococcal conjugate vaccines include the quadrivalent vaccines (MenACWY-DT, Men-ACWY-CRM, and MenACWY-TT) as well as the monovalent A and C vaccines. These conjugate vaccines were shown to elicit strong immune response in adults. This review addresses the various aspects of meningococcal disease, the limitations posed by polysaccharide vaccines, the different conjugate vaccines with their immunogenicity and reactogenicity in adults, and the current recommendations in adults. © 2014 Landes Bioscience.
dc.format.extent
dc.format.extent Pages: (995-1007)
dc.language English
dc.publisher Landes Bioscience; AUSTIN
dc.relation.ispartof Publication Name: Human Vaccines and Immunotherapeutics; Publication Year: 2014; Volume: 10; no. 4; Pages: (995-1007);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Review of meningococcal vaccines with updates on immunization in adults
dc.type Review
dc.contributor.affiliation Zahlanie, Y.C., Center for Infectious Diseases Research, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Hammadi, M.M., Center for Infectious Diseases Research, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Ghanem, S.T., Department of Pediatrics, Makassed General Hospital, Beirut, Lebanon
dc.contributor.affiliation Dbaibo, G.S., Center for Infectious Diseases Research, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
dc.contributor.authorAddress Dbaibo, G.S.; Center for Infectious Diseases Research, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon; email: gdbaibo@aub.edu.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Pediatrics and Adolescent Medicine;
dc.contributor.authorDepartment Pediatrics and Adolescent Medicine
dc.contributor.authorDivision
dc.contributor.authorEmail gdbaibo@aub.edu.lb
dc.contributor.faculty Faculty of Medicine
dc.contributor.authorInitials Zahlanie, YC
dc.contributor.authorInitials Hammadi, MM
dc.contributor.authorInitials Ghanem, ST
dc.contributor.authorInitials Dbaibo, GS
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Dbaibo, GS (reprint author), Amer Univ Beirut, Div Pediat Infect Dis, Ctr Infect Dis Res, Dept Pediat and Adolescent Med,Med Ctr, Beirut, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Al-Tawfiq JA, 2012, EUROSURVEILLANCE, V17, P6; Al-Tawfiq JA, 2010, J TRAVEL MED, V17, P3, DOI 10.1111-j.1708-8305.2010.00448.x; [Anonymous], 2012, SUMM PROD CHAR NIM E; [Anonymous], 2011, WKLY EPIDEMIOL REC, V86, P521; [Anonymous], 2013, WKLY EPIDEMIOL REC, V88, P129; [Anonymous], 2013, GREEN BOOK, P235; [Anonymous], 2012, SUMM PROD CHAR MENJ; [Anonymous], 2013, UNLICENSED VACCINE P; [Anonymous], 2013, MEN MEN INF SHEET HL; [Anonymous], 2013, U PROVIDES MENINGITI; [Anonymous], 2012, SUMM PROD CHAR MEN; Aplasca-De Los Reyes MR, 2012, HUM VACC IMMUNOTHER, V8, P881, DOI 10.4161-hv.20212; ARMAND J, 1982, J BIOL STAND, V10, P335, DOI 10.1016-S0092-1157(82)80010-3; Artenstein AW, 2012, VACCINE, V30, P4701, DOI 10.1016-j.vaccine.2012.04.024; Baltimore RS, 2006, CURR OPIN PEDIATR, V18, P58, DOI 10.1097-01.mop.0000193265.78506.7f; Barnett ED, 2013, VACCINES, P1270; Bermal N, 2011, HUM VACCINES, V7, P239, DOI 10.4161-hv.7.2.14068; Bilukha O, 2007, PEDIATR INFECT DIS J, V26, P371, DOI 10.1097-01.inf.0000259996.95965.ef; Borja-Tabora C, 2013, BMC INFECT DIS, V13, DOI 10.1186-1471-2334-13-116; Borrow R, 2009, TRAVEL MED INFECT DI, V7, P219, DOI 10.1016-j.tmaid.2009.05.003; Borrow R, 2000, VACCINE, V19, P1129, DOI 10.1016-S0264-410X(00)00317-0; Bridges CB, 2013, MMWR SURVEILL SUMM, V62, P9; Broderick MP, 2012, EMERG INFECT DIS, V18, P1430, DOI 10.3201-eid1809.120257; Broker M, 2010, TRAVEL MED INFECT DI, V8, P47, DOI 10.1016-j.tmaid.2009.12.001; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128-CMR.00070-09; Cadoz M, 1998, VACCINE, V16, P1391, DOI 10.1016-S0264-410X(98)00097-8; Fang Jing, 2011, Morbidity and Mortality Weekly Report, V60, P1377; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P1009; Farley M. M., 2010, Morbidity and Mortality Weekly Report, V59, P253; Ceyhan M, 2013, CLIN VACCINE IMMUNOL, V20, P66, DOI 10.1128-CVI.00314-12; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147-CLEP.S28410; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016-S1473-3099(10)70251-6; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Cohn AJ., 2011, INFECT DIS RELATED T; Brady MT, 2011, PEDIATRICS, V128, P1213, DOI 10.1542-peds.2011-2380; Cooper B, 2011, EXPERT REV VACCINES, V10, P21, DOI [10.1586-erv.10.147, 10.1586-ERV.10.147]; Cramer JP, 2012, CURR OPIN INFECT DIS, V25, P507, DOI 10.1097-QCO.0b013e3283574c06; Croxtall JD, 2012, DRUGS, V72, P2407, DOI 10.2165-11209580-000000000-00000; Dbaibo G, 2012, INT J INFECT DIS, V16, pE608, DOI 10.1016-j.ijid.2012.04.006; Dbaibo G, 2012, HUM VACC IMMUNOTHER, V8, P873, DOI 10.4161-hv.20211; Dbaibo G, 2013, DRUG AGING, V30, P309, DOI 10.1007-s40266-013-0065-0; de Souza AL, 2011, TROPICAL INFECT DIS, P174; Dellicour S, 2007, TROP MED INT HEALTH, V12, P1409, DOI 10.1111-j.1365-3156.2007.01929.x; Duffield K, 2007, XPHARM COMPREHENSIVE, P1; Elias J, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186-1745-6673-8-4; Erickson LJ, 2001, CLIN INFECT DIS, V33, P737, DOI 10.1086-322587; FINNE J, 1983, LANCET, V2, P355; Flitter BA, 2007, HUM VACCINES, V3, P135; Frasch CE, 2012, HUM VACC IMMUNOTHER, V8, P715, DOI 10.4161-hv.19619; Gardner P, 2006, NEW ENGL J MED, V355, P1466, DOI 10.1056-NEJMcp063561; Gasparini R, 2010, CLIN VACCINE IMMUNOL, V17, P537, DOI 10.1128-CVI.00436-09; Geretti AM, 2008, HIV MED, V9, P795, DOI 10.1111-j.1468-1293.2008.00637.x; Ghanem S, 2013, EXPERT OPIN BIOL TH, V13, P1197, DOI 10.1517-14712598.2013.812629; Girard MP, 2006, VACCINE, V24, P4692, DOI 10.1016-j.vaccine.2006.03.034; GOLD R, 1979, J INFECT DIS, V140, P690; Goldblatt D, 2002, J INFECT DIS, V185, P397, DOI 10.1086-338474; GOLDSCHN.I, 1969, J EXP MED, V129, P1327, DOI 10.1084-jem.129.6.1327; GOLDSCHN.I, 1969, J EXP MED, V129, P1307, DOI 10.1084-jem.129.6.1307; Grand Rounds CDC, 2012, MMWR-MORBID MORTAL W, V61, P1017; Granoff DM, 2013, VACCINES, P388; Granoff DM, 2007, PEDIATR INFECT DIS J, V26, P716, DOI 10.1097-INF.0b013e3180cc2c25; Granoff DM, 1998, J INFECT DIS, V178, P870; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086-648966; GRIFFISS JM, 1982, INFECT IMMUN, V37, P205; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016-j.vaccine.2011.12.032; Harris SL, 2003, INFECT IMMUN, V71, P3402, DOI 10.1128-IAI.71.6.3402-3408.2003; Harrison Lee H, 2011, Vaccine, V29, P3363, DOI 10.1016-j.vaccine.2011.02.058; Harrison Lee H, 2009, Vaccine, V27 Suppl 2, pB51, DOI 10.1016-j.vaccine.2009.04.063; Harrison LH, 2006, CLIN MICROBIOL REV, V19, P142, DOI 10.1128-CMR.19.1.142-164.2006; HASSANKING MKA, 1988, J INFECTION, V16, P55, DOI 10.1016-S0163-4453(88)96117-8; Healy CM, 2012, CLIN OBSTET GYNECOL, V55, P474, DOI 10.1097-GRF.0b013e31824f3acb; Hebert CJ, 2012, HUM VACC IMMUNOTHER, V8, P560, DOI 10.4161-hv.19204; Husain EH, 2010, MED PRIN PRACT, V19, P321, DOI 10.1159-000312721; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016-S0140-6736(02)08416-7; Joshi VS, 2009, CARBOHYD POLYM, V75, P553, DOI 10.1016-j.carbpol.2008.09.032; Keiser PB, 2012, HUM VACC IMMUNOTHER, V8, P582, DOI 10.4161-hv.19517; Kimmel Sanford R, 2008, Ther Clin Risk Manag, V4, P739; Kimmel SR, 2005, AM FAM PHYSICIAN, V72, P2049; Kirkpatrick BD, 2003, CURR OPIN INFECT DIS, V16, P369, DOI 10.1097-01.qco.0000092806.64370.57; Koch S, 1994, J TRAVEL MED, V1, P4, DOI 10.1111-j.1708-8305.1994.tb00548.x; Koyfman A, 2011, AM J EMERG MED, V1, P174; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016-j.vaccine.2007.04.049; Lakshman R, 2002, VACCINE, V20, P3778, DOI 10.1016-S0264-410X(02)00318-3; Lingappa JR, 2003, EMERG INFECT DIS, V9, P665; MacNeil JR, 2011, MENINGOCOCCAL DIS VP, P1; Maiden MCJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098-rstb.2012.0147; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016-S0140-6736(12)61187-8; Memish ZA, 2002, SAUDI MED J, V23, P259; Memish Ziad A, 2010, J Infect Public Health, V3, P143, DOI 10.1016-j.jiph.2010.09.008; Memish ZA, 2003, INT J ANTIMICROB AG, V21, P96, DOI 10.1016-S0924-8579(02)00364-3; Mertz Lori, 2011, Nurse Pract, V36, P12, DOI 10.1097-01.NPR.0000398844.35575.51; Miller JM, 2011, ADV PREV MED, V2011; MOORE PS, 1988, JAMA-J AM MED ASSOC, V260, P2686, DOI 10.1001-jama.260.18.2686; Nadel S, 2012, ARCH DIS CHILD, V97, P993, DOI 10.1136-archdischild-2012-302036; National Advisory Committee on Immunization, 2013, CAN COMMUN DIS REP, V39, P1; Ostergaard L, 2013, INT J INFECT DIS, V17, pE173, DOI 10.1016-j.ijid.2012.10.001; Pace D, 2012, VACCINE, V30, pB3, DOI 10.1016-j.vaccine.2011.12.062; Papaevangelou V, 2012, EXPERT REV VACCINES, V11, P523, DOI [10.1586-erv.12.32, 10.1586-ERV.12.32]; PATEL M, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002-14651858.CD001093.PUB2; Poland GA, 2010, CLIN INFECT DIS, V50, pS45, DOI 10.1086-648964; Pollard Andrew J, 2004, Pediatr Infect Dis J, V23, pS274; Poolman J, 2011, EXPERT REV VACCINES, V10, P307, DOI [10.1586-erv.11.8, 10.1586-ERV.11.8]; Prasad K, 2007, RESP MED, V101, P2037, DOI 10.1016-j.rmed.2007.06.030; Public Helath England, 2013, CHANG MEN C CONJ MEN; Raghunathan PL, 2004, ANNU REV MED, V55, P333, DOI 10.1146-annurev.med.55.091092.103612; Ramsay M., 2012, GUIDANCE PUBLIC HLTH, P1; REINGOLD AL, 1985, LANCET, V2, P114; Reisinger KS, 2009, CLIN VACCINE IMMUNOL, V16, P1810, DOI 10.1128-CVI.00207-09; Richmond P, 1999, VACCINE, V18, P641, DOI 10.1016-S0264-410X(99)00276-5; Richmond P, 2000, J INFECT DIS, V181, P761, DOI 10.1086-315284; Riordan A, 2010, CURR OPIN NEUROL, V23, P319, DOI 10.1097-WCO.0b013e3283381751; Rohner GB, 2013, PEDIAT INFECT DIS J; Rosenstein N, 1998, JAMA-J AM MED ASSOC, V279, P435, DOI 10.1001-jama.279.6.435; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056-NEJM200105033441807; Rouphael NG, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P1061, DOI 10.1016-B978-0-12-369408-9.00053-6; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007-978-1-61779-346-2_1; Serino L, 2006, DRUG DISCOV TODAY TH, V3, P129, DOI 10.1016-j.ddstr.2006.06.011; Shao PL, 2009, J FORMOS MED ASSOC, V108, P539, DOI 10.1016-S0929-6646(09)60371-5; Smith MJ, 2008, EXPERT OPIN BIOL TH, V8, P1941, DOI 10.1517-14712590802538455 ; Southern J, 2004, CLIN DIAGN LAB IMMUN, V11, P1100, DOI 10.1128-CDLI.11.6.1100-1104.2004; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056-NEJMoa1003812; Steffen R, 2010, J TRAVEL MED, V17, P9, DOI 10.1111-j.1708-8305.2010.00449.x; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111-j.1574-6976.2006.00051.x; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016-S0140-6736(07)61016-2; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016-j.vaccine.2009.04.070; Sullivan MG, ACIP RECOMMENDS MENI; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056-NEJMra0906357; Teyssou R, 2007, VACCINE, V25, pA3, DOI 10.1016-j.vaccine.2007.04.032; Toneatto D, 2011, HUM VACCINES, V7, P781, DOI 10.4161-hv.7.7.15997; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P101, DOI 10.1111-j.1574-6976.2006.00053.x; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016-S1286-4579(00)00356-7; Vaughn JA, 2011, AM FAM PHYSICIAN, V84, P1015; Vipond C, 2012, VACCINE, V30, pB10, DOI 10.1016-j.vaccine.2011.12.060; Vu DM, 2006, CLIN VACCINE IMMUNOL, V13, P605, DOI 10.1128-CVI.00123-06; Wilder-Smith Annelies, 2008, Travel Med Infect Dis, V6, P182, DOI 10.1016-j.tmaid.2007.10.002; Wilder-Smith A, 2010, EPIDEMIOL INFECT, V138, P976, DOI 10.1017-S095026880999104X; World Health Organization, 2012, WHO FACT SHEET MEN M; Yogev R, 2011, HUM VACCINES, V7, P828, DOI 10.4161-hv.7.8.16270; Zheteyeva Y, 2013, AM J OBSTET GYNECOL, V208, pe1
dc.description.citedCount
dc.description.citedTotWOSCount 1
dc.description.citedWOSCount 1
dc.format.extentCount 13
dc.identifier.articleNo
dc.identifier.coden
dc.identifier.pubmedID
dc.identifier.scopusID 84899825254
dc.identifier.url
dc.publisher.address 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Human Vaccines Immunother.
dc.relation.ispartOfIssue 4
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Human Vaccines and Immunotherapeutics
dc.relation.ispartofPubTitleAbbr Hum. Vaccines Immunother.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 10
dc.source.ID WOS:000336655000029
dc.type.publication Journal
dc.subject.otherAuthKeyword Adults
dc.subject.otherAuthKeyword Meningococcal conjugate vaccine
dc.subject.otherAuthKeyword Meningococcal disease
dc.subject.otherAuthKeyword Meningococcal polysaccharide vaccine
dc.subject.otherAuthKeyword Neisseria meningitidis
dc.subject.otherAuthKeyword Recommendations
dc.subject.otherChemCAS ampicillin, 69-52-3, 69-53-4, 7177-48-2, 74083-13-9, 94586-58-0
dc.subject.otherIndex ampicillin
dc.subject.otherIndex chickenpox measles mumps rubella vaccine
dc.subject.otherIndex diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine
dc.subject.otherIndex diphtheria toxoid
dc.subject.otherIndex hepatitis A hepatitis B vaccine
dc.subject.otherIndex host factor
dc.subject.otherIndex influenza vaccine
dc.subject.otherIndex measles mumps rubella vaccine
dc.subject.otherIndex meningococcal conjugate quadrivalent vaccine
dc.subject.otherIndex Meningococcus vaccine
dc.subject.otherIndex menjugate kit
dc.subject.otherIndex penicillin derivative
dc.subject.otherIndex Pneumococcus vaccine
dc.subject.otherIndex polysaccharide vaccine
dc.subject.otherIndex priorix tetra
dc.subject.otherIndex unclassified drug
dc.subject.otherIndex allergic reaction
dc.subject.otherIndex antibiotic prophylaxis
dc.subject.otherIndex antibody titer
dc.subject.otherIndex arthralgia
dc.subject.otherIndex bacterial colonization
dc.subject.otherIndex bacterium isolation
dc.subject.otherIndex drug efficacy
dc.subject.otherIndex drug safety
dc.subject.otherIndex fatigue
dc.subject.otherIndex fever
dc.subject.otherIndex gastrointestinal symptom
dc.subject.otherIndex geographic distribution
dc.subject.otherIndex headache
dc.subject.otherIndex human
dc.subject.otherIndex immune response
dc.subject.otherIndex immunization
dc.subject.otherIndex immunogenicity
dc.subject.otherIndex immunological memory
dc.subject.otherIndex incidence
dc.subject.otherIndex injection site erythema
dc.subject.otherIndex injection site pain
dc.subject.otherIndex injection site reaction
dc.subject.otherIndex malaise
dc.subject.otherIndex meningococcosis
dc.subject.otherIndex myalgia
dc.subject.otherIndex nausea
dc.subject.otherIndex Neisseria meningitidis
dc.subject.otherIndex opsonization
dc.subject.otherIndex pain
dc.subject.otherIndex paresthesia
dc.subject.otherIndex pathogenesis
dc.subject.otherIndex practice guideline
dc.subject.otherIndex review
dc.subject.otherIndex seasonal influenza
dc.subject.otherIndex seizure
dc.subject.otherIndex somnolence
dc.subject.otherIndex species invasion
dc.subject.otherIndex swelling
dc.subject.otherIndex virus strain
dc.subject.otherKeywordPlus TOXOID CONJUGATE VACCINE
dc.subject.otherKeywordPlus MENINGITIDIS SEROGROUP-C
dc.subject.otherKeywordPlus POLYSACCHARIDE VACCINE
dc.subject.otherKeywordPlus NEISSERIA-MENINGITIDIS
dc.subject.otherKeywordPlus UNITED-STATES
dc.subject.otherKeywordPlus GROUP-A
dc.subject.otherKeywordPlus MENACWY-TT
dc.subject.otherKeywordPlus BACTERIAL-MENINGITIS
dc.subject.otherKeywordPlus YOUNG-ADULTS
dc.subject.otherKeywordPlus CURRENT RECOMMENDATIONS
dc.subject.otherWOS Biotechnology and Applied Microbiology
dc.subject.otherWOS Immunology


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account